Venus Medtech Hangzhou Inc
OTC:VMTHF

Watchlist Manager
Venus Medtech Hangzhou Inc Logo
Venus Medtech Hangzhou Inc
OTC:VMTHF
Watchlist
Price: 0.4219 USD
Market Cap: $12.4B

Wall St Price Targets

VMTHF Price Targets Summary
Venus Medtech Hangzhou Inc

There are no price targets for VMTHF.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
Venus Medtech Hangzhou Inc Competitors:
Price Targets

Revenue
Forecast

15% / Year
Past Growth
87% / Year
Estimated Growth
Estimates Accuracy
-17%
Average Miss
15% / Year
Past Growth
87% / Year
Estimated Growth
Estimates Accuracy
-17%
Average Miss

Over the last 7 years, the compound annual growth rate for Revenue has been 15%. The projected CAGR for the next 2 years is 87%.

Gross Profit
Forecast

11% / Year
Past Growth
97% / Year
Estimated Growth
Estimates Accuracy
-20%
Average Miss
11% / Year
Past Growth
97% / Year
Estimated Growth
Estimates Accuracy
-20%
Average Miss

Over the last 7 years, the compound annual growth rate for Gross Profit has been 11%. The projected CAGR for the next 2 years is 97%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
69%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
69%
Average Beat

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
95%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
95%
Average Beat

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average Beat/Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is VMTHF's stock price target?
Not Available

VMTHF does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for Venus Medtech Hangzhou Inc?
Projected CAGR
87%

Over the last 7 years, the compound annual growth rate for Revenue has been 15%. The projected CAGR for the next 2 years is 87%.

What is the Gross Profit forecast for Venus Medtech Hangzhou Inc?
Projected CAGR
97%

Over the last 7 years, the compound annual growth rate for Gross Profit has been 11%. The projected CAGR for the next 2 years is 97%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett